48144 Federal Register / Vol. 86, No. 164 / Friday, August 27, 2021 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–21–1102] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled Tuberculosis 

Data from Panel Physicians to the Office 

of Management and Budget (OMB) for 

review and approval. CDC previously 

published a ‘‘Proposed Data Collection 

Submitted for Public Comment and 

Recommendations’’ notice on May 26, 

2021 to obtain comments from the 

public and affected agencies. CDC 

received one non-substantive comment 

related to the previous notice. This 

notice serves to allow an additional 30 

days for public and affected agency 

comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

Tuberculosis Data from Panel 

Physicians (OMB Control No. 0920– 

1102, Exp. 9/30/2021)—Revision— 

National Center for Emerging and 

Zoonotic Infectious Diseases (NCEZID), 

Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

The Centers for Disease Control and 

Prevention’s (CDC), National Center for 

Emerging and Zoonotic Infectious 

Diseases (NCEZID), Division of Global 

Migration and Quarantine (DGMQ), 

Immigrant, Refugee, and Migrant Health 

Branch (IRMH), requests approval for a 

Revision to an approved information 

collection. The respondents are U.S. 

panel physicians. Panel physicians are 

medically trained, licensed, and 

experienced medical doctors practicing 

overseas who are appointed by the local 

U.S. Embassy or Consulate General to 

perform medical examinations for 

prospective immigrants to the United 

States. More than 760 panel physicians 

perform overseas pre-departure medical 

examinations at 336 panel sites, in 

accordance with requirements, referred 

to as Technical Instructions, provided 

by the Centers for Disease Control and 

Prevention’s Division of Global 

Migration and Quarantine, Quality 

Assessment Program (QAP). The QAP 

program is housed in the Immigrant, 

Refugee, and Migrant Health Branch 

(IRMH). The role of QAP is to assist and 

guide panel physicians in the 

implementation of the Technical 

Instructions; evaluate the quality of the 

overseas medical examination for U.S.- 

bound immigrants and refugees; assess 

potential panel physician sites; and 

provide recommendations to the U.S. 

Department of State in matters of 

immigrant medical screening. 

To achieve DGMQ’s mission, IRMH 

works with domestic and international 

programs to improve the health of U.S.- 

bound immigrants and refugees to 

protect the U.S. public by preventing 

the importation of infectious disease. 

These goals are accomplished through 

IRMH’s oversight of medical exams 

required for all U.S.-bound immigrants 

and refugees who seek permanent 

residence in the U.S. IRMH is 

responsible for assisting and training the 

international panel physicians with the 

implementation of medical exam 

Technical Instructions. CDC’s Technical 

Instructions are detailed requirements 

and national policies regarding the 

medical screening and treatment of all 

U.S.-bound immigrants and refugees. 

Screening for tuberculosis (TB) is a 

particularly important component of the 

immigration medical exam and allows 

panel physicians to diagnose active TB 

disease prior to arrival in the United 

States. As part of the Technical 

Instructions requirements, panel 

physicians perform chest x-rays and 

laboratory tests that aid in the 

identification of tuberculosis infection 

(Class B1 applicants) and diagnosis of 

active tuberculosis disease (Class A, 

inadmissible applicants). CDC uses 

these classifications to report new 

immigrant and refugee arrivals with a 

higher risk of developing TB disease to 

U.S. state and local health departments 

for further follow-up. Some information 

that panel physicians collect as part of 

the medical exam is not reported on the 

standard Department of State forms (DSforms), thereby preventing CDC from 

evaluating TB trends in globally mobile 

populations and monitoring program 

effectiveness. 

In 2007, CDC revised the Tuberculosis 

Technical Instructions to include 

several new requirements for 

Mycobacteria tuberculosis (MTB) testing 

and treatment. Important changes 

included the requirements for: (1) 

Sputum cultures in addition to sputum 

smears; (2) tuberculin skin tests or 

interferon gamma release assays 

(beginning in 2009) for certain children 

aged 2–14 years examined in countries 

where the World Health Organization 

estimated TB incidence is ≥20 per 

100,000 persons; (3) drug-susceptibility 

testing of positive isolates; and (4) 

treatment being delivered as directly 

observed therapy (DOT) throughout the 

entire course. 

Since implementation of these new 

Culture and Directly Observed Therapy 

TB Technical Instructions (CDOT TB 

TI), overseas TB case detection has 

increased by an estimated 60% and 

allowed U.S. public health programs to 

save millions of dollars annually. 

Overseas TB screening data (referred to 

by DGMQ as ‘TB Indicator data’) is 

critical to support the continued 

analysis of these trends and the 

monitoring of TB control efforts in the 

U.S. 

CDC requests this data collection 

approval for three years. This Revision 

includes a decrease in respondents from 

336 to 333, and a decrease in the 

requested number of burden hours from 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 86, No. 164 / Friday, August 27, 2021 / Notices 48145 

1,008 hours to 999. There is no cost to respondents other than their time to 

participate. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

International Panel Physicans ........................ TB Indicators REDCap web form .................. 333 1 3 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2021–18539 Filed 8–26–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–21–1182] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled ‘‘Formative 

Research to Develop HIV Social 

Marketing Campaigns for Healthcare 

Providers’’ to the Office of Management 

and budget (OMB) for review and 

approval. CDC previously published a 

‘‘Proposed Data Collection Submitted 

for Public Comment and 

Recommendations’’ notice on March 8, 

2021 to obtain comments from the 

public and affected agencies. CDC did 

not receive comments related to the 

previous notice. This notice serves to 

allow an additional 30 days for public 

and affected agency comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

Formative Research to Develop HIV 

Social Marketing Campaigns for 

Healthcare Providers (OMB Control No. 

0920–1182)—Reinstatement without 

Change—National Center for HIV/AIDS, 

Viral Hepatitis, STD and TB Prevention 

(NCHHSTP), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

To address the HIV epidemic in the 

U.S., the Department of Health and 

Human Services launched Ending the 

HIV Epidemic: A Plan for America, 

which is a cross-agency initiative 

aiming to reduce new HIV infections in 

the U.S. by 90% by 2030. CDC’s Let’s 

Stop HIV Together campaign (formerly 

known as Act Against AIDS) is part of 

the national Ending the HIV Epidemic 

initiative and includes resources aimed 

at reducing HIV stigma and promoting 

testing, prevention, and treatment across 

the HIV care continuum. 

Within this context, CDC’s Division of 

HIV/AIDS Prevention (DHAP) has, and 

will continue implementing various 

communication initiatives to increase 

healthcare providers’ awareness of HIV 

testing-, prevention- and treatmentrelated topics; reduce new HIV 

infections among disproportionately 

impacted populations; and improve 

health outcomes for people living with 

HIV/AIDS in the US and its territories. 

Specifically, the initiatives target 

healthcare providers, including primary 

care, and relevant specialties such as 

HIV medicine and infectious disease, 

physicians, physician assistants, and 

nurses. 

The rounds of data collection include 

exploratory, message testing, concept 

testing, and materials testing. 

Information collected by DHAP will be 

used to assess healthcare providers’ 

informational needs about topics related 

to HIV testing, prevention, and 

treatment; pre-test campaign-related 

messages, concepts, and materials; and 

evaluate the extent to which the 

communication initiatives are reaching 

the target audiences and providing them 

with trusted HIV-related information. 

Data collections will include in-depth 

interviews and brief surveys. The data 

gathered under this request will be 

summarized in reports prepared for CDC 

by its contractor, such as quarterly and 

annual reports and topline reports that 

summarize results from each data 

collection. It is possible that data from 

this project will be published in peerreviewed manuscripts or presented at 

conferences, and the manuscripts and 

conference presentations may appear on 

the internet. 

The total estimated annualized 

burden hours are 902. Participation of 

respondents is voluntary, and there is 

no cost to participants other than their 

time. 


lotter on DSK11XQN23PROD with NOTICES1